| Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors (NCT04933669) | First Affiliated Hospital of Zhejiang University | 2021-09-07 |
| Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor (NCT04256226) | Far Eastern Memorial Hospital | 2020-02-01 |
| A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and Malignant Nodules (NCT04143048) | The First Affiliated Hospital with Nanjing Medical University | 2019-09-01 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST (NCT02924714) | Oslo University Hospital | 2017-01-01 |
| Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor (NCT02931981) | RenJi Hospital | 2016-10-01 |
| Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tumors (NCT02884154) | Pusan National University Hospital | 2016-08-01 |
| A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors (NCT02686944) | Mendus | 2016-06-01 |
| the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor (NCT02763748) | First Affiliated Hospital Xi'an Jiaotong University | 2016-06-01 |
| A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST (NCT02776878) | Peking University Cancer Hospital & Institute | 2016-05-01 |
| Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor (NCT02734823) | University of Southern California | 2016-03-01 |
| Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index (NCT02576080) | Assistance Publique Hopitaux De Marseille | 2015-10-01 |
| Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery (NCT02426762) | First Affiliated Hospital, Sun Yat-Sen University | 2015-02-01 |
| Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy (NCT02185937) | Radboud University Medical Center | 2014-08-01 |
| Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST (NCT02164240) | Dana-Farber Cancer Institute | 2014-07-01 |
| Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions (NCT02103322) | Amneal Pharmaceuticals, LLC | 2014-02-01 |
| Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST (NCT02353052) | Shanghai Zhongshan Hospital | 2013-07-01 |
| Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy (NCT01865565) | Chang Gung Memorial Hospital | 2013-01-01 |
| Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle (NCT01769248) | Northwestern University | 2012-09-01 |
| Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic (NCT01643278) | National Cancer Institute (NCI) | 2012-07-01 |
| A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film-coated Tablet 100mg (4 Tablets)(Phase I) (NCT01751919) | Dong-A ST Co., Ltd. | 2012-05-01 |
| A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor (NCT02336724) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors (NCT01560260) | National Cancer Institute (NCI) | 2012-03-01 |
| Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor (NCT01404650) | SCRI Development Innovations, LLC | 2011-12-01 |
| A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients (NCT01389583) | National Health Research Institutes, Taiwan | 2011-10-01 |
| EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration (NCT01774162) | University of Alberta | 2011-09-01 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma (NCT01154452) | National Cancer Institute (NCI) | 2010-06-01 |
| Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (NCT01068769) | Suzanne George, MD | 2010-02-01 |
| A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST) (NCT01039519) | Synta Pharmaceuticals Corp. | 2010-01-01 |
| Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate (NCT00956072) | European Organisation for Research and Treatment of Cancer - EORTC | 2009-05-01 |
| Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001 (NCT00954655) | Alliance for Clinical Trials in Oncology | 2008-12-01 |
| Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor (NCT00769782) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2008-10-01 |
| Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors (NCT00777504) | Radboud University Medical Center | 2008-10-01 |
| Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor (NCT00764595) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2008-10-01 |
| Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT01110668) | Novartis Pharmaceuticals | 2008-09-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor (NCT00324987) | National Cancer Institute (NCI) | 2008-04-01 |
| Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors (NCT00568750) | Swiss Cancer Institute | 2008-01-22 |
| Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors (NCT00573404) | Vanderbilt-Ingram Cancer Center | 2007-07-01 |
| A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. (NCT00428220) | Pfizer | 2007-07-01 |
| Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (NCT00372567) | Pfizer | 2007-06-01 |
| Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer (NCT00397384) | National Cancer Institute (NCI) | 2007-01-01 |
| Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After Previous Treatment With Imatinib Mesylate and Sunitinib Malate (NCT00265798) | National Cancer Institute (NCI) | 2005-09-14 |
| Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery (NCT00091078) | National Cancer Institute (NCI) | 2005-09-01 |
| Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor (NCT00112632) | Technical University of Munich | 2005-02-01 |
| Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma (NCT00112463) | National Cancer Institute (NCI) | 2005-01-07 |
| Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor (NCT00103168) | European Organisation for Research and Treatment of Cancer - EORTC | 2004-12-01 |
| Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery (NCT00098579) | National Cancer Institute (NCI) | 2004-10-01 |
| CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor (NCT00087074) | National Cancer Institute (NCI) | 2004-06-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Removed By Surgery (NCT00041197) | National Cancer Institute (NCI) | 2002-06-01 |
| Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood (NCT00030667) | National Cancer Institute (NCI) | 2002-05-01 |
| Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma (NCT00041249) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-05-01 |
| Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointestinal Stromal Tumor (NCT00028002) | National Cancer Institute (NCI) | 2002-03-31 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor (NCT00685828) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor (NCT00069940) | Dana-Farber Cancer Institute | 2000-12-01 |
| Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor (NCT00009906) | National Cancer Institute (NCI) | 2000-12-01 |
| S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors (NCT00005597) | SWOG Cancer Research Network | 2000-04-01 |
| Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (NCT00004910) | Northwestern University | 2000-01-01 |
| Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (NCT00004911) | Northwestern University | 2000-01-01 |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery (NCT00004895) | Northwestern University | 1999-10-01 |
| Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas (NCT00005874) | Astex Pharmaceuticals, Inc. | 1999-06-01 |
| Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer (NCT00005049) | NYU Langone Health | 1997-05-01 |
| Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination (NCT01613053) | Novartis Pharmaceuticals | |
| Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019) (NCT03493152) | The University of Texas Health Science Center at San Antonio | |